Tarsus Pharmaceuticals Inc (TARS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Tarsus Pharmaceuticals Inc   (NASDAQ: TARS)
 

Tarsus Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Tarsus Pharmaceuticals Inc inventory turnover ratio, the Tarsus Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 10.2 in the second quarter 2026, a new company high. Average inventory processing period, for the Tarsus Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 36 days, compare to 40 days, in the Mar 31 2026 quarter.

Within Healthcare sector 32 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 348.

TARS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Tarsus Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TARS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 13.01 % 69.02 % 66.87 % 34.79 % 76.45 %
Y / Y Cost of Sales Growth 94.21 % 80.31 % 182.62 % 156.29 % 107.62 %
Inventory Turnover Ratio (TTM) 10.2 9.09 9.11 7.57 6.51
TARS's Total Ranking # 348 # 348 # 161 # 321 #
Average inventory processing period 36 40 40 48 56
Seq. Inventory Growth -4.27 % 4.57 % 13.97 % -0.96 % 43.18 %
Seq. Cost of Sales Growth 28.92 % -32.51 % 67.55 % 33.22 % 19.69 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 33
Overall Market # 348

Inventory Turnover Ratio Statistics
High Average Low
10.2 6.54 2.67
(Jun 30 2026)   (Jun 30 2024)



TARS Company Profile >> Back to TARS Efficiency Comparisons >> Compare TARS Inventory Turnover Ratio to its Competitors

Financial Statements
Tarsus Pharmaceuticals Inc 's Inventories $ 4 Millions Visit TARS's Balance sheet
Tarsus Pharmaceuticals Inc 's Cost of Revenues TTM $ 44 Millions Visit TARS's Income Statement
What are TARS's Sales? Visit TARS's Sales by Segment

Other Inventory Turnover Ratios
Tarsus Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TARS's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TARS's Competitors
Inventory Turnover Ratio for TARS's Suppliers
Inventory Turnover Ratio for TARS's Customers

You may also want to know
TARS's Sales Growth Rates TARS's Pe Price to earnings ratio TARS's Receivables Turnover Ratio TARS's Stock Quote
TARS's Net Income Growth Rates TARS's Ps Price to Sales ratio TARS's Sales per Employee TARS's Asset Turnover Ratio
TARS's Net Margin TARS's Pb Price to Book ratio TARS's Financial Strength Ratios TARS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Prophase Labs Inc   26.86 $ 3.196  Millions$ 0  Millions
Omada Health Inc   24.96 $ 97.232  Millions$ 4  Millions
Viemed Healthcare Inc   24.71 $ 128.283  Millions$ 5  Millions
Teladoc Health Inc   22.32 $ 772.590  Millions$ 35  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Adapthealth Corp   20.25 $ 2,676.899  Millions$ 132  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Labcorp Holdings Inc   19.29 $ 10,203.900  Millions$ 529  Millions
Aspira Women s Health inc   19.13 $ 5.073  Millions$ 0  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.